A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.
Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the ...
Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced topline results from VOCAL, an ...
Nearsightedness in childhood can mean headaches, learning difficulties and the cost and inconvenience of glasses or contacts.
Have we heard from Sigfrido Ranucci? No, to tell the truth, we haven't heard from him. We expect a good luck wish, from him as from all the people who have participated in this Report adventure.” ...
US Secretary of State Marco Rubio is reportedly considering resigning and distancing himself from US President Donald Trump after the Republican defeat in the Midterm elections. The Independent writes ...
Australia has approved its first GLP-1 weight-loss tablet, giving people an alternative to weekly injections such as Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results